4//SEC Filing
Sun Elaine D 4
Accession 0001179110-21-003974
CIK 0001159036other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 7:43 PM ET
Size
9.3 KB
Accession
0001179110-21-003974
Insider Transaction Report
Form 4
Sun Elaine D
SVP, Chief Financial Officer
Transactions
- Exercise/Conversion
Performance Stock Units
2021-04-01−10,196→ 30,600 totalExercise: $0.00→ Common Stock (10,196 underlying) - Exercise/Conversion
Common Stock
2021-04-01+10,196→ 18,077 total - Tax Payment
Common Stock
2021-04-01$42.43/sh−4,059$172,223→ 14,018 total
Footnotes (2)
- [F1]The reported disposition of 4,059 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
- [F2]Each earned Performance Stock Unit (PSU) is settled by delivery of one share of common stock. The vesting of these PSUs was subject to the satisfaction of both performance-based and time-based vesting conditions. The performance-based condition was satisfied as to 25% of the total PSU grant upon achievement of each of four separate milestones of 20%, 30%, 40% and 50% average increases over 20 consecutive trading days of the closing price of the Issuer's common stock on the date of grant. The time-based condition will be satisfied as to 25% of the total PSU grant upon each of the first four anniversaries of the date of grant contingent upon the Reporting Person's continued service to the Issuer through each such anniversary date. Subject to the terms of the PSU award agreement, the performance-based conditions of the PSU grant were certified as satisfied on July 2, 2020. Therefore, vesting of these PSUs remains subject only to the time-based vesting conditions.
Documents
Issuer
HALOZYME THERAPEUTICS, INC.
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0001805339
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 7:43 PM ET
- Size
- 9.3 KB